serena williams on glp 1 Says GLP-1s Could Have Made Her Even Better at Tennis Inside Serena Williams' partnership with

Both drugs share the same dual-agonist mechanism

Last reviewed: July 10, 2026 Last updated: July 10, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

By slowing down the digestive process, reducing appetite, and regulating blood sugar levels, these medications offer a promising avenue for effective and holistic weight loss

Gut Health Emerges as Massive Market For many consumers, the quest for good gut health has just begun and businesses are ready like Viome, a healthtech and longevity startup that raised $87 million for its at-home microbiome testing kit

This approach helps in choosing an ideal treatment with the least possible side effects or harm